Physician profile
Jaspreet Kaur
NPI 1497913206
$1,600.39
in general payments reported to CMS, 2019-2025
16 companies · $921 in 2025
The $921 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.77 · 2020: $185 · 2021: $111 · 2022: $74.58 · 2023: $138 · 2024: $136 · 2025: $921.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,152 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,152.29 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beta Bionics, INC. | $563.62 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Abbott Laboratories | $180.31 | 2024-2025 | Freestyle Libre 3 |
| Mannkind Corporation | $161.30 | 2020-2025 | |
| Madrigal Pharmaceuticals | $121.62 | 2024 | Resmetirom |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.48 | 2025 | Jardiance |
| Novo Nordisk INC | $102.57 | 2021-2023 | |
| Amgen INC. | $88.00 | 2020 | |
| Dexcom, INC. | $82.67 | 2021-2023 | Dexcom G6 Transmitter |
| Medtronic, INC. | $31.21 | 2022 | |
| Abbvie INC. | $30.20 | 2022-2023 | |
| Merz Pharmaceuticals, LLC | $29.68 | 2025 | Xeomin |
| Sanofi-Aventis U.S. LLC | $22.86 | 2020 | |
| Pulmonx Corporation | $20.09 | 2019 | |
| Sunovion Pharmaceuticals INC. | $17.11 | 2021 | |
| Boston Scientific Corporation | $14.99 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaspreet Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.